Efficacy and safety of increased doses of anticoagulants in COVID-19 patients: A systematic review and meta-analysis
The aim of the study was to evaluate the efficacy and safety of increased doses of anticoagulants in comparison with standard doses in inpatients with COVID-19. A systematic review was carried out in October 2021 using the PubMed database. The analysis included only randomized clinical trials (RCTs)...
Main Authors: | Evgeny Stepanov, Kirill Lobastov, Sergey Tsaplin, Ilya Schastlivtsev, Astanda Bargandzhiya, Leonid Laberko, Grigoriy Rodoman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Vascular Investigation and Therapy |
Subjects: | |
Online Access: | http://www.vitonline.org/article.asp?issn=2589-9686;year=2022;volume=5;issue=3;spage=59;epage=67;aulast=Stepanov |
Similar Items
-
EXTENDED THERAPY OF VENOUS THROMBOSIS BY ORAL ANTICOAGULANTS: FOCUS AT SAFETY
by: I. V. SCHASTLIVTSEV, et al.
Published: (2016-12-01) -
The current approaches to the management of coronavirus disease 2019 associated coagulopathy
by: Kirill Lobastov, et al.
Published: (2020-01-01) -
Direct oral anticoagulants in cancer-associated venous thromboembolism
by: Kirill Lobastov, et al.
Published: (2020-01-01) -
Thrombosis of pulmonary vasculature despite anticoagulation and thrombolysis: The findings from seven autopsies
by: O. Porembskaya, et al.
Published: (2020-12-01) -
The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment
by: К. V. Lobastov, et al.
Published: (2020-05-01)